Tesamorelin + Ipamorelin
A stabilized GHRH analog paired with a selective ghrelin-receptor agonist for dual-pathway endocrine research.
Research Overview
Tesamorelin is a trans-3-hexenoyl derivative of human GHRH(1-44), a modification studied for its resistance to dipeptidyl peptidase-4 degradation relative to native GHRH. It is investigated at the GHRH receptor.
Ipamorelin acts at the growth-hormone secretagogue receptor and is characterised in the literature for receptor selectivity.
Specifications
| Compound | Tesamorelin + Ipamorelin |
| Classification | Endocrine research compound |
| Constituents | Tesamorelin 5 mg — 5,135.9 g/mol Ipamorelin 5 mg — 711.85 g/mol |
| Molecular weight | Blend — see constituents |
| Sequence / Form | Tesamorelin 5 mg · Ipamorelin 5 mg |
| Purity | ≥98% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
